Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06003790 · ClinicalTrials.gov registry record · NA
Facilitators and Barriers to the Clinical Implementation of MR-001
A NA study of Chronic Stroke, sponsored by MedRhythms.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 3
- Study locations
NCT06003790 is a NA study of Chronic Stroke that has completed, run by MedRhythms. The registered enrollment target is 31 participants, below the 42-participant average among 20 other Chronic Stroke trials with a reported enrollment target (26% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06003790, a NA study of Chronic Stroke, has completed, sponsored by MedRhythms.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a single arm, multi-site, prospective hybrid implementation and feasibility trial. The primary purpose of this trial is to gather data on the facilitators and barriers to clinical implementation of MR-001 for patients with chronic stroke who experience walking impairments. Secondarily, the trial will evaluate the feasibility of MR-001 clinically impacting walking capacity, quality of life, mood, and cognition. The goal of this single arm, multi-site, prospective hybrid implementation and feasibility trial is to gather data on the facilitators and barriers to clinical implementation of MR-001 for patient with chronic stroke who experience walking impairments. The main questions it aims to answer are: 1. Enhance understanding of the potential clinical and operational needs and opportunities that may be associated with implementation of MR-001 in various treatment settings. 2. Assess the impact of MR-001 on walking capacity. 3. Assess the impact of MR-001 on quality of life and mood. 4. Assess the impact of MR-001 on cognition. All participants will be prescribed MR-001 and will be asked to walk with it for 30 minutes, 3 times weekly, for 8 weeks.
Conditions Studied
Interventions
- DEVICE MR-001
Study Locations (3)
Massachusetts
- Massachusetts General Hospital - Boston
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Ohio
- The Cleveland Clinic Foundation - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2023-08-29 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06003790
The ClinicalTrials.gov registry entry for NCT06003790 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 42-participant average among 20 other Chronic Stroke trials with a reported enrollment target (26% lower). The listed sponsor is MedRhythms, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Stroke appearing as the primary indexed condition, and to 1 intervention - of which MR-001 is the first listed.
NCT06003790 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, North Carolina, Ohio.
Frequently Asked Questions
What is clinical trial NCT06003790 about?
NCT06003790 is a clinical study titled "Facilitators and Barriers to the Clinical Implementation of MR-001". This is a single arm, multi-site, prospective hybrid implementation and feasibility trial. The primary purpose of this trial is to gather data on the facilitators and barriers to clinical implementation of MR-001 for patients with chronic stroke who experience walking impairments. Secondarily, the t...
What is the current status of trial NCT06003790?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2023-08-29. Estimated completion is 2024-04-30.
What conditions does trial NCT06003790 study?
This clinical trial studies the following conditions: Chronic Stroke.
What interventions are being tested in trial NCT06003790?
The interventions under investigation include: MR-001 (DEVICE).
Who is sponsoring clinical trial NCT06003790?
This trial is sponsored by MedRhythms, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06003790 being conducted?
This trial has 3 study locations across Massachusetts, North Carolina, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hand and Arm Motor Recovery Via Non-invasive Electrical Spinal Cord Stimulation After Stroke
RECRUITING · NA
-
Effect of NMES on Balance and Fall Risk in Chronic Stroke
RECRUITING · NA
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Paired Vagus Nerve Stimulation Mechanisms
RECRUITING · NA
-
Home-based FES Training in People With Chronic Stroke
RECRUITING · NA
-
Exoskeleton Research: Myoelectric Orthosis for Rehab of Severe Chronic Arm Motor Deficits
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.